Latest filing published 24 Aug 2010 for Anika Therapeutics, Inc., €3,989.
Insider track record
No signal scores available.
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +18.2%Entry US$5.00 · Close at T+365 US$5.91
- -45.6%Entry US$8.61 · Close at T+365 US$4.68
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
William Mrachek: trading record in brief
William Mrachek is a declared insider of Anika Therapeutics, Inc., with filings sourced from SEC (Form 4). The record holds 3 filings, for trades running from 10 March 2008 to 23 August 2010.
Purchases make up the whole of the open-market record (2 purchases, €6,974). Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 1 share grant. So far in 2010, the count stands at 1 purchase and no sales.
Most recently, on 24 August 2010, the filings show an open-market purchase worth €3,989 in Anika Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to William Mrachek
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,000 shares@ US$5.04Common StockSEC:0001140361-10-034762:0Canonical exit: 21 Nov 2010 (T+90)
- 4,254 shares0Common StockSEC:0001104659-09-021365:0
- 500 shares@ US$9.16Common StockSEC:0001104659-08-017095:0Canonical exit: 8 Jun 2008 (T+90)
3 of 3 declarations
